Table 2.
Characteristics of Patients Treated With Intravenous Thrombolysis, Stratified by Treatment Group
| Characteristic | MSU Care (n=29) | Conventional Care (n=9) | P Value |
|---|---|---|---|
| Age, mean (SD) | 76.1 (15.6) | 73.1 (11.1) | 0.68 |
| Male sex | 15 (51.7) | 6 (66.7) | 0.48 |
| Racea | 0.65 | ||
| Black | 3 (10.3) | 1 (11.1) | |
| Asian | 2 (6.9) | 0 (0.0) | |
| Latino/Hispanic | 8 (27.6) | 5 (55.6) | |
| White | 13 (44.8) | 3 (33.3) | |
| Initial NIHSS, mean (SD) | 9.2 (6.9) | 12.9 (7.9) | 0.19 |
| Translator used | 5 (17.2) | 2 (22.2) | >0.99 |
| Finger stick, mg/dL, mean (SD) | 153.0 (65.0) | 154.0 (71.0) | 0.97 |
| Initial systolic BP, mm Hg, mean (SD) | 162.0 (28.0) | 161.0 (31.0) | 0.89 |
| Initial diastolic BP, mm Hg, mean (SD) | 88.0 (20.0) | 81.0 (18.0) | 0.34 |
| Baseline mRSb | 0.66 | ||
| 0 | 16 (55.2) | 5 (55.6) | |
| 1 | 2 (6.9) | 1 (11.1) | |
| 2 | 1 (3.4) | 0 (0.0) | |
| 3 | 1 (3.4) | 2 (22.2) | |
| 4 | 2 (6.9) | 0 (0.0) | |
| 5 | 2 (6.9) | 1 (11.1) | |
| Post‐tPA symptomatic intracranial hemorrhage | 1 (3.4) | 0 (0.0) | >0.99 |
| Presence of stroke risk factors | |||
| History of stroke | 8 (27.6) | 4 (44.4) | 0.44 |
| Diabetes mellitus | 10 (34.5) | 3 (33.3) | >0.99 |
| Hypertension | 19 (65.5) | 6 (66.7) | >0.99 |
| Atrial fibrillation | 6 (20.7) | 1 (11.1) | >0.99 |
| Coronary artery disease | 6 (20.7) | 5 (55.6) | 0.09 |
| Active smoking | 1 (3.4) | 1 (11.1) | 0.96 |
| Peripheral vascular disease | 2 (6.9) | 0 (0.0) | >0.99 |
| Final diagnosis | 0.57 | ||
| Acute ischemic stroke | 21 (72.4) | 8 (88.9) | |
| Stroke mimic | 8 (27.6) | 1 (11.1) | |
Data are reported as n (%) unless otherwise noted. BP indicates blood pressure; mRS, modified Rankin scale; MSU, mobile stroke unit; NIHSS, National Institutes of Health Stroke Scale; tPA, tissue plasminogen activator.
a
Race data missing for 6 MSU patients.
b
mRS data missing for 5 MSU patients and 1 conventional care patient who were lost to follow‐up.